Ibrutinib medical insurance reimbursement scope
Ibrutinibis a prescription drug with limited reimbursement coverage by medical insurance1.Treatment of patients with mantle cell lymphoma(MCL) who have received at least one treatment in the past. 2.Chronic lymphocytic leukemia(CLL)/Small lymphocytic tumor(CLL/SLL)Treatment of patients. 3.For the treatment of patients with Waldenström's macroalbuminemia, use the medicine according to the instructions.

Metabolism is the main elimination pathway of ibrutinib. It is metabolized to several metabolites mainly by cytochrome P450 (CYP) 3A and to a lesser extent by CYP2D6. The active metabolite PCI-45227 is a dihydrodiol metabolite whose inhibitory activity against BTK is approximately 15 times lower than ibrutinib. PCI-45227The average metabolite to parent ratio at steady state ranges from 1 to 2.8.
Ibrutinibmainly exists in the form of metabolites and is mainly excreted in the feces. After a single oral dose of radiolabeled ibrutinib, 90% of the radioactivity was excreted within 168 hours, of which 80% was excreted in the feces and less than 10% was excreted in the urine. Unaltered ibrutinib accounted for 1% of the radiolabeled dose excreted in the feces, no radiolabeled dose was excreted in the urine, and the remainder of the excreted dose was metabolites. There are generic drugs in Bangladesh, Laos and India. The retail price of Ziska Pharmaceuticals in Bangladesh is more than 140mg120capsules2 more than a thousand. The retail price of Istar Pharmaceuticals in Bangladesh140mg90capsules2 is more than a thousand. Bangladesh Everest Pharmaceutical retail price140mg120tablets2About a thousand. The retail price of Beacon Pharmaceuticals in Bangladesh is around 140 mg 120 tablets 4 around one thousand. The retail price of Bangladesh Yaopin International Pharmaceutical140mg112 capsules2 is more than a thousand. IndiaNATCOPharmaceutical retail price9more than 100. The retail price of pharmaceuticals in Laos and ASEAN is more than 1,000 for 140 mg 90 tablets. Patients can choose drug versions based on their financial situation. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)